Recent Earnings News
Where is HTHT's stock going now?
Down
Flat
Up
HTHT

H World Group reports

Monday, March 27, 2023 8:56:00 PM

H World Group (HTHT) reported a 4th Quarter December 2022 loss of $0.06 per share on revenue of $537.0 million. on revenue of $542.7 million.

China Lodging Group Ltd is a multi-brand hotel group in China with leased, manachised and franchised models.

H World Group reports Earnings Whispers
Where is NOAH's stock going now?
Down
Flat
Up
NOAH

Noah Holdings Ltd ADR reports

Monday, March 27, 2023 6:00:00 PM

Noah Holdings Ltd ADR (NOAH) reported 4th Quarter December 2022 earnings of $0.31 per share on revenue of $127.9 million. on revenue of $132.1 million.

Noah Holdings Ltd., is an independent service provider focusing on distributing wealth management products to the high net worth population in China. It provides direct access to China’s high net worth population.

Noah Holdings Ltd ADR reports Earnings Whispers
Where is EE's stock going now?
Down
Flat
Up
EE

Excelerate Energy Inc Cl A reports

Monday, March 27, 2023 5:35:00 PM

Excelerate Energy Inc Cl A (EE) reported 4th Quarter December 2022 earnings of $0.26 per share on revenue of $455.1 million. The consensus earnings estimate was $0.14 per share on revenue of $237.0 million.

Excelerate Energy, Inc. is a US-based LNG company located in The Woodlands, Texas.

Excelerate Energy Inc Cl A reports Earnings Whispers
Where is GROY's stock going now?
Down
Flat
Up
GROY

Gold Royalty reports

Monday, March 27, 2023 5:18:00 PM

Gold Royalty (GROY) reported a 1st Quarter December 2022 loss of $0.02 per share on revenue of $0.6 million. The consensus estimate was a loss of $0.01 per share on revenue of $8.1 million.

Gold Royalty is a gold-focused royalty company offering creative financing solutions to the metals and mining industry.

Gold Royalty reports Earnings Whispers
Where is GROY's stock going now?
Down
Flat
Up
GROY

Gold Royalty reports

Monday, March 27, 2023 5:18:00 PM

Gold Royalty (GROY) reported a 1st Quarter December 2022 loss of $0.02 per share on revenue of $0.6 million. The consensus estimate was a loss of $0.01 per share on revenue of $8.1 million.

Gold Royalty is a gold-focused royalty company offering creative financing solutions to the metals and mining industry.

Gold Royalty reports Earnings Whispers
Where is GRNT's stock going now?
Down
Flat
Up
GRNT

Granite Ridge Resources reports

Monday, March 27, 2023 5:00:00 PM

Granite Ridge Resources (GRNT) reported 4th Quarter December 2022 earnings of $0.38 per share on revenue of $116.3 million. The consensus earnings estimate was $0.47 per share.

Granite Ridge is a scaled, non-operated oil & gas exploration and production company.

Granite Ridge Resources reports Earnings Whispers
Where is OPAL's stock going now?
Down
Flat
Up
OPAL

Opal Fuels reports

Monday, March 27, 2023 5:00:00 PM

Opal Fuels (OPAL) reported 4th Quarter December 2022 earnings of $0.18 per share on revenue of $66.7 million. The consensus earnings estimate was $0.05 per share on revenue of $72.2 million.

OPAL Fuels Inc. is a leading vertically integrated renewable fuels platform involved in the production and distribution of renewable natural gas (RNG) for the heavy-duty truck market.

Opal Fuels reports Earnings Whispers
Where is DPRO's stock going now?
Down
Flat
Up
DPRO

Draganfly reports

Monday, March 27, 2023 4:53:00 PM

Draganfly (DPRO) reported a 4th Quarter December 2022 loss of $0.30 per share on revenue of $1.0 million. The consensus estimate was a loss of $0.11 per share on revenue of $1.8 million.

Draganfly reports Earnings Whispers
Where is KORE's stock going now?
Down
Flat
Up
KORE

KORE Sees Revenue Above Estimates

Monday, March 27, 2023 4:39:00 PM

Kore Group Holdings (KORE) reported a 4th Quarter December 2022 loss of $0.15 per share on revenue of $62.4 million. The consensus estimate was a loss of $0.13 per share on revenue of $60.9 million.

The company said it expects 2023 revenue of $300.0 million to $310.0 million. The current consensus revenue estimate is $280.68 million for the year ending December 31, 2023.

KORE is a pioneer, leader, and trusted advisor delivering mission critical IoT solutions and services.

KORE Sees Revenue Above Estimates Earnings Whispers
Where is CTMX's stock going now?
Down
Flat
Up
CTMX

Cytomx Thera Misses

Monday, March 27, 2023 4:15:00 PM

Cytomx Thera (CTMX) reported a 4th Quarter December 2022 loss of $0.42 per share on revenue of $0.9 million. The consensus estimate was a loss of $0.21 per share on revenue of $17.9 million. The Earnings Whisper number was for a loss of $0.22 per share.

Cytomx Thera Misses Earnings Whispers
Where is LWAY's stock going now?
Down
Flat
Up
LWAY

Lifeway Foods reports

Monday, March 27, 2023 4:15:00 PM

Lifeway Foods (LWAY) reported 4th Quarter December 2022 earnings of $0.05 per share on revenue of $35.8 million. on revenue of $39.0 million.

Lifeway Foods Inc manufactures probiotic, cultured, functional dairy and non-dairy health food products.

Lifeway Foods reports Earnings Whispers
Where is MDWT's stock going now?
Down
Flat
Up
MDWT

Midwest Holding reports

Monday, March 27, 2023 4:15:00 PM

Midwest Holding (MDWT) reported a 4th Quarter December 2022 loss of $1.34 per share on revenue of $8.6 million. on revenue of $18.2 million.

Midwest Holding Inc. is a rapidly growing, technology-enabled, services-oriented annuity platform. Midwest designs and develops in-demand annuity products that are distributed through independent distribution channels, to a large and growing demographic of U.S. retirees. Midwest originates, manages and transfers these annuities through reinsurance arrangements to asset managers and other third-party investors, who are actively seeking these financially attractive products. Midwest also provides the operational and regulatory infrastructure and expertise to enable asset managers and third-party investors to form, capitalize and manage their own reinsurance capital vehicles.

Midwest Holding reports Earnings Whispers
Where is PVH's stock going now?
Down
Flat
Up
PVH

Phillips-Van Heusen Beats

Monday, March 27, 2023 4:15:00 PM

Phillips-Van Heusen (PVH) reported 4th Quarter January 2023 earnings of $2.38 per share on revenue of $2.5 billion. The consensus earnings estimate was $1.64 per share on revenue of $2.4 billion. The Earnings Whisper number was $1.68 per share.

The company said it expects fiscal 2023 earnings of approximately $10.00 per share on revenue of $9.295 billion to $9.385 billion. The current consensus earnings estimate is $8.83 per share on revenue of $9.19 billion for the year ending January 31, 2024.

PVH Corp is an apparel company, which designs and markets branded dress shirts, neckwear, sportswear and, to a lesser extent, footwear and other related products.

Phillips-Van Heusen Beats Earnings Whispers
Where is RAIL's stock going now?
Down
Flat
Up
RAIL

FreightCar America Sees Revenue Below Estimates

Monday, March 27, 2023 4:15:00 PM

Freightcar America (RAIL) reported a 4th Quarter December 2022 loss of $0.31 per share on revenue of $129.0 million. The consensus estimate was a loss of $0.14 per share on revenue of $118.6 million.

The company said it expects 2023 revenue of $400.0 million to $430.0 million. The current consensus revenue estimate is $501.60 million for the year ending December 31, 2023.

FreightCar America Inc is a manufacturer of aluminum-bodied railcars in North America. The Company specializes in production of coal cars.

FreightCar America Sees Revenue Below Estimates Earnings Whispers
Where is INLX's stock going now?
Down
Flat
Up
INLX

Intellinetics reports

Monday, March 27, 2023 4:06:00 PM

Intellinetics (INLX) reported 4th Quarter December 2022 earnings of $0.04 per share on revenue of $4.0 million. on revenue of $3.7 million.

Intellinetics, Inc., located in Columbus, Ohio, is a cloud-based document services software provider.

Intellinetics reports Earnings Whispers
Where is FGI's stock going now?
Down
Flat
Up
FGI

FGI Industries Guides In-line

Monday, March 27, 2023 4:05:00 PM

Fgi Industries (FGI) reported 4th Quarter December 2022 earnings of $0.11 per share on revenue of $31.8 million. The consensus earnings estimate was $0.12 per share on revenue of $35.7 million.

The company said it expects 2023 revenue of $145.0 million to $163.0 million. The current consensus revenue estimate is $154.78 million for the year ending December 31, 2023.

FGI Industries Ltd. is a leading global supplier of kitchen and bath products.

FGI Industries Guides In-line Earnings Whispers
Where is HARP's stock going now?
Down
Flat
Up
HARP

Harpoon Therapeutics reports

Monday, March 27, 2023 4:05:00 PM

Harpoon Therapeutics (HARP) reported a 4th Quarter December 2022 loss of $0.55 per share on revenue of $4.1 million. The consensus estimate was a loss of $0.43 per share on revenue of $7.0 million.

Harpoon Therapeutics reports Earnings Whispers
Where is RGTI's stock going now?
Down
Flat
Up
RGTI

Rigetti Computing reports

Monday, March 27, 2023 4:05:00 PM

Rigetti Computing (RGTI) reported a 4th Quarter December 2022 loss of $0.19 per share on revenue of $6.1 million. The consensus estimate was a loss of $0.12 per share on revenue of $4.4 million.

Rigetti is a pioneer in full-stack quantum computing.

Rigetti Computing reports Earnings Whispers
Where is SRT's stock going now?
Down
Flat
Up
SRT

Startek reports

Monday, March 27, 2023 4:05:00 PM

Startek (SRT) reported 4th Quarter December 2022 earnings of $0.30 per share on revenue of $93.0 million. The consensus earnings estimate was $0.11 per share on revenue of $169.8 million.

StarTek Inc is a provider of business process outsourcing services. Its services include customer care, sales support, inbound sales, complex order processing, accounts receivable management, technical and product support, up-sell and cross-sell.

Startek reports Earnings Whispers
Where is TERN's stock going now?
Down
Flat
Up
TERN

Terns Pharmaceuticals reports

Monday, March 27, 2023 4:05:00 PM

Terns Pharmaceuticals (TERN) reported a 4th Quarter December 2022 loss of $0.29 per share on revenue of $0.0 million. The consensus estimate was a loss of $0.42 per share.

Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology, NASH and obesity.

Terns Pharmaceuticals reports Earnings Whispers
Where is CCL's stock going now?
Down
Flat
Up
CCL

Carnival Beats but Guides Lower

Monday, March 27, 2023 9:15:00 AM

Carnival (CCL) reported a 1st Quarter February 2023 loss of $0.55 per share on revenue of $4.4 billion. The consensus estimate was a loss of $0.62 per share on revenue of $4.3 billion. The Earnings Whisper number was for a loss of $0.59 per share.

The company said it expects a second quarter loss of $0.42 to $0.34 per share and fiscal a 2023 loss of $0.44 to $0.28 per share. The current consensus estimate is a loss of $0.29 per share for the quarter ending May 31, 2023 and a loss of $0.17 per share for the year ending November 30, 2023.

Carnival Corp is a leisure travel company operating a portfolio of 100 cruise ships. Its brands include Carnival Cruise Lines, in North America; P&O Cruises and Cunard in the UK; AIDA Cruises in Germany; Costa Cruises in Southern Europe.

Carnival Beats  but Guides Lower Earnings Whispers
Where is SLRX's stock going now?
Down
Flat
Up
SLRX

Salarius Pharmaceuticals reports

Monday, March 27, 2023 8:30:00 AM

Salarius Pharmaceuticals (SLRX) reported a 4th Quarter December 2022 loss of $2.83 per share on revenue of $0.0 million. The consensus estimate was a loss of $2.07 per share.

Salarius Pharmaceuticals reports Earnings Whispers
Where is DCTH's stock going now?
Down
Flat
Up
DCTH

Delcath Systems reports

Monday, March 27, 2023 8:20:00 AM

Delcath Systems (DCTH) reported a 4th Quarter December 2022 loss of $0.86 per share on revenue of $0.6 million. The consensus estimate was a loss of $0.68 per share on revenue of $0.8 million.

Delcath Systems, Inc. is an interventional oncology company focused on the treatment of primary and metastatic liver cancers. Our investigational product, HEPZATO KIT (melphalan hydrochloride for injection/hepatic delivery system), is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.

Delcath Systems reports Earnings Whispers
Where is HTHT's stock going now?
Down
Flat
Up
HTHT

H World Group Sees Revenue Above Estimates

Monday, March 27, 2023 8:15:00 AM

H World Group (HTHT) reported a 4th Quarter December 2022 loss of $0.06 per share on revenue of $537.0 million. on revenue of $542.7 million.

The company said it expects 2023 revenue of $2.85 billion to $2.94 billion. The current consensus revenue estimate is $2.71 billion for the year ending December 31, 2023.

China Lodging Group Ltd is a multi-brand hotel group in China with leased, manachised and franchised models.

H World Group Sees Revenue Above Estimates Earnings Whispers
Where is VAXX's stock going now?
Down
Flat
Up
VAXX

Vaxxinity Inc Cl A reports

Monday, March 27, 2023 7:50:00 AM

Vaxxinity Inc Cl A (VAXX) reported a 4th Quarter December 2022 loss of $0.16 per share on revenue of $0.0 million. The consensus estimate was a loss of $0.16 per share.

Vaxxinity Inc Cl A reports Earnings Whispers
Where is RGF's stock going now?
Down
Flat
Up
RGF

Real Good Food Company Reaffirms

Monday, March 27, 2023 7:30:00 AM

The Real Good Food Company Inc Cl A (RGF) reported 4th Quarter December 2022 earnings of $0.12 per share on revenue of $35.7 million. The consensus estimate was a loss of $0.11 per share on revenue of $49.3 million.

The company said it continues to expect 2023 revenue of at least $200.0 million. The current consensus revenue estimate is $200.92 million for the year ending December 31, 2023.

Real Good Foods is a leading health and wellness frozen foods company, providing a better way to enjoy your favorite foods.

Real Good Food Company Reaffirms Earnings Whispers
Where is RPHM's stock going now?
Down
Flat
Up
RPHM

Reneo Pharmaceuticals reports

Monday, March 27, 2023 7:30:00 AM

Reneo Pharmaceuticals (RPHM) reported a 4th Quarter December 2022 loss of $0.56 per share on revenue of $0.0 million. The consensus estimate was a loss of $0.62 per share.

Reneo is a clinical stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP).

Reneo Pharmaceuticals reports Earnings Whispers
Where is ABOS's stock going now?
Down
Flat
Up
ABOS

Acumen Pharmaceuticals reports

Monday, March 27, 2023 7:00:00 AM

Acumen Pharmaceuticals (ABOS) reported a 4th Quarter December 2022 loss of $0.32 per share on revenue of $0.0 million. The consensus estimate was a loss of $0.28 per share.

Acumen is a clinical stage biopharmaceutical company developing a novel disease-modifying approach to treat Alzheimer’s disease.

Acumen Pharmaceuticals reports Earnings Whispers
Where is AUGX's stock going now?
Down
Flat
Up
AUGX

Augmedix Sees Revenue Above Estimates

Monday, March 27, 2023 7:00:00 AM

Augmedix (AUGX) reported a 4th Quarter December 2022 loss of $0.15 per share on revenue of $8.8 million. The consensus estimate was a loss of $0.15 per share on revenue of $8.5 million.

The company said it expects 2023 revenue of approximately $42.0 million. The current consensus revenue estimate is $40.25 million for the year ending December 31, 2023.

Augmedix, Inc. is a leading digital health platform that offers virtual medical documentation and live clinical support to large healthcare systems and physician practices, supporting medical offices, clinics, hospitals, emergency departments and telemedicine practices nationwide.

Augmedix Sees Revenue Above Estimates Earnings Whispers
Where is GMDA's stock going now?
Down
Flat
Up
GMDA

Gamida Cell reports

Monday, March 27, 2023 7:00:00 AM

Gamida Cell (GMDA) reported a 4th Quarter December 2022 loss of $0.29 per share on revenue of $0.0 million. The consensus estimate was a loss of $0.24 per share.

Gamida Cell reports Earnings Whispers
Where is VERO's stock going now?
Down
Flat
Up
VERO

Venus Concept Sees Revenue Below Estimates

Monday, March 27, 2023 7:00:00 AM

Venus Concept (VERO) reported a 4th Quarter December 2022 loss of $0.14 per share on revenue of $24.3 million. on revenue of $23.8 million.

The company said it expects 2023 revenue of $90.0 million to $95.0 million. The current consensus revenue estimate is $103.49 million for the year ending December 31, 2023. The company said it expects 2023 revenue of $90.0 million to $95.0 million. The current consensus estimate is revenue of $103.49 million for the year ending December 31, 2023.

Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reach in over 60 countries and 21 direct markets.

Venus Concept Sees Revenue Below Estimates Earnings Whispers
Where is BNTX's stock going now?
Down
Flat
Up
BNTX

Biontech Se ADR Beats but Guides Lower

Monday, March 27, 2023 6:45:00 AM

Biontech Se ADR (BNTX) reported 4th Quarter December 2022 earnings of $9.46 per share on revenue of $4.4 billion. The consensus earnings estimate was $8.04 per share on revenue of $4.4 billion. The Earnings Whisper number was $9.36 per share.

The company said it expects 2023 revenue of approximately $5.39 billion. The current consensus revenue estimate is $8.80 billion for the year ending December 31, 2023.

Biopharmaceutical New Technologies is a next generation immunotherapy company pioneering novel therapies for cancer and other serious diseases.

Biontech Se ADR Beats  but Guides Lower Earnings Whispers
Where is PHI's stock going now?
Down
Flat
Up
PHI

Philippine Long Distance Telephone ADR reports

Saturday, March 25, 2023 11:22:00 AM

Philippine Long Distance Telephone ADR (PHI) reported 4th Quarter December 2022 earnings of $0.60 per share on revenue of $962.7 million..

Philippine Long Distance Telephone, provides telecommunication services. It offers wireless services, fixed line services and business process outsourcing services.

Philippine Long Distance Telephone ADR reports Earnings Whispers
Where is IMPL's stock going now?
Down
Flat
Up
IMPL

Impel Pharmaceuticals reports

Friday, March 24, 2023 8:17:00 AM

Impel Pharmaceuticals (IMPL) reported a 4th Quarter December 2022 loss of $0.97 per share on revenue of $5.0 million. The consensus estimate was a loss of $1.04 per share on revenue of $5.0 million.

Impel NeuroPharma, Inc. is a late-stage pharmaceutical company focused on utilizing its proprietary technology to develop and commercialize transformative therapies for people suffering from diseases with high unmet needs, with an initial focus on diseases of the CNS.

Impel Pharmaceuticals reports Earnings Whispers
Where is VACC's stock going now?
Down
Flat
Up
VACC

Vaccitech Plc ADR reports

Friday, March 24, 2023 8:06:00 AM

Vaccitech Plc ADR (VACC) reported a 4th Quarter December 2022 loss of $0.55 per share on revenue of $6.5 million. The consensus estimate was a loss of $0.43 per share on revenue of $3.3 million.

Vaccitech is a clinical-stage biopharmaceutical company focused on the development of novel T cell immunotherapeutics designed to utilize the power of the immune system to potentially treat and cure chronic infectious diseases, autoimmune diseases, and cancer.

Vaccitech Plc ADR reports Earnings Whispers
Where is ASLN's stock going now?
Down
Flat
Up
ASLN

Aslan Pharmaceuticals Ltd ADR reports

Friday, March 24, 2023 7:00:00 AM

Aslan Pharmaceuticals Ltd ADR (ASLN) reported a 4th Quarter December 2022 loss of $1.04 per share on revenue of $0.0 million. The consensus estimate was a loss of $0.95 per share.

Aslan Pharmaceuticals Ltd ADR reports Earnings Whispers
Where is HUMA's stock going now?
Down
Flat
Up
HUMA

Humacyte reports

Friday, March 24, 2023 7:00:00 AM

Humacyte (HUMA) reported a 4th Quarter December 2022 loss of $0.21 per share on revenue of $0.0 million. The consensus estimate was a loss of $0.24 per share on revenue of $0.2 million.

Humacyte, Inc. is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine.

Humacyte reports Earnings Whispers
Where is LPTX's stock going now?
Down
Flat
Up
LPTX

Leap Therapeutics reports

Friday, March 24, 2023 7:00:00 AM

Leap Therapeutics (LPTX) reported a 4th Quarter December 2022 loss of $0.11 per share on revenue of $0.0 million. The consensus estimate was a loss of $0.09 per share on revenue of $1.2 million.

Leap Therapeutics is focused on developing targeted and immuno-oncology therapeutics. Leap's most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein.

Leap Therapeutics reports Earnings Whispers
Where is ATAI's stock going now?
Down
Flat
Up
ATAI

Atai Life Sciences N.V. reports

Friday, March 24, 2023 6:59:00 AM

Atai Life Sciences N.V. (ATAI) reported a 4th Quarter December 2022 loss of $0.28 per share on revenue of $0.0 million. The consensus estimate was a loss of $0.23 per share on revenue of $0.1 million.

atai Life Sciences is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders.

Atai Life Sciences N.V. reports Earnings Whispers
Where is EXPR's stock going now?
Down
Flat
Up
EXPR

Express Guides Below Estimates

Friday, March 24, 2023 6:45:00 AM

Express (EXPR) reported a 4th Quarter January 2023 loss of $0.63 per share on revenue of $514.3 million. The consensus estimate was a loss of $0.72 per share on revenue of $536.7 million.

The company said it expects a first quarter loss of $0.80 to $0.70 per share and fiscal a 2024 loss of $1.05 to $0.85 per share. The current consensus estimate is a loss of $0.47 per share for the quarter ending April 30, 2023 and a loss of $0.67 per share for the year ending January 31, 2024.

Express, Inc., is a specialty apparel and accessory retailer offering both women' and men' merchandise. The Company operates in single segment which is Express brick-and-mortar retail stores and e-commerce operations.

Express Guides Below Estimates Earnings Whispers